← Open Payments lookup

AQEEL KHAN: Open Payments

NPI 1629046735 · BLOOMINGDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$470 in 21 payments from 9 companies in 2025. Trend: 2023 $578 · 2024 $483 · 2025 $470

Food & beverage: $470
CompanyPaymentsAmount
ABBVIE INC.5$97
Otsuka America Pharmaceutical, Inc.1$78
Janssen Pharmaceuticals, Inc4$78
Teva Pharmaceuticals USA, Inc.4$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Lundbeck LLC2$36
Luye Pharma (USA) Ltd.1$26
Axsome Therapeutics, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$20

Products named: VRAYLAR, ABILIFY MAINTENA, INVEGA SUSTENNA, UZEDY, CAPLYTA, REXULTI, ERZOFRI EXTENDED-RELEASE, Auvelity.

Industry payments across IL — which companies pay providers there.